This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. A new vaccine developed by the Serum Institute of India to fight meningococcal disease could help eliminate meningitis across Africa. percentage points (96% CI, −0.3
Finch Therapeutics’s Phase III PRISM4 trial for recurrent Clostridioides difficile infection (CDI) and MaaT Pharma’s Phase III trial in steroid-resistant acute graft-versus-host disease were both put on hold. While the French MaaT Pharma has submitted further information to the FDA, its trial remains on hold. with placebo.
Additionally, it will work on non-clinical toxicity (TOX) and Clinical Trial Material batch to conduct a Phase I clinical trial of the vaccine in healthy adult subjects. This trial will evaluate the safety of the vaccine and generate efficacy data. A sexually transmitted disease, gonorrhoea is caused by the NG bacteria.
Columbia Engineering researchers report that they have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells in mice. Using Bacteria For Therapy. Some trials had to be terminated due to severe toxicity.”
These study participants, representing approximately half of the total recruited participants in the trial, are being discontinued following violations of Good Clinical Practice (GCP) at certain clinical trial sites run by a third-party clinical trial site operator.
Remarkable drop was observed in altered filamin A plasma levels after treatment with simufilam in Phase 2b trials. a biotechnology (clinical stage immuno-oncology) company from California publicized the design of its new XPro therapy in Phase 2 clinical trials. P-tau 181 plasma levels were also reduced in a good amount. gingivalis.
The WHO contained a Marburg virus outbreak in Tanzania in early 2024 with nine cases and six deaths. Universal vaccines, such as a pan-coronavirus candidate in late-stage trials, aim to provide cross-protection against multiple strains. Global travel further accelerates disease spread, complicating containment efforts.
Antiseptic creams are preparations which are applied to the skin to reduce the possibility of infections or to slow the growth of bacteria. Antiseptic creams have bacteriostatic properties (stops bacteria from multiplying) as opposed to antibiotic creams, which are bactericidal (kill the bacteria). .
Throat numbing lozenges contain a local anaesthetic which numbs the area and hence help with pain and irritation. This post list all sore throat lozenges containing a local anaesthetic available in the UK. Sore throat lozenges, which contain a local anaesthetic as an active ingredient, are classified as pharmacy-only products (P).
Often the bacteria develop antibiotic resistance to certain drugs, leaving it non-effective for the usage the second time in the case of recurrence of the infection that occurs in approximately 30-35% of the uUTI cases, therefore, leaving a serious dearth of the new antibiotics. coli bacteria called FimH.
CDIs typically develop after the use of antibiotics, which can wipe out the gut’s healthy bacteria. Seres’ microbiome drug SER-109 aims to restore the healthy bacteria via an oral capsule that contains a protective species of gut bacteria. Difficile infection (CDI).
The Toronto-based company has recently announced positive results from an independent clinical trial which showed that their fluorescence imaging device MolecuLight i :X improved 12-week wound healing of diabetic foot ulcers by 204 percent. The challenge is that other specialities have diagnostic imaging to assist clinicians.
The microbiome, as a term, can be related to the nasal, oral, skin, gastro-intestinal, and urogenital regions of the human body, each containing varied microbial communities that have an impact on health. In the trial, Seres announced that the product candidate had met its primary endpoint, showing a statistically significant 30.2%
difficile as certain antibiotics can disrupt the balance of bacteria in the gut, allowing bacteria like C. Additionally, Rebyota could contain food allergens, which poses an unknown risk for food allergen-related adverse reactions. The use of certain antibiotics can contribute to infection caused by C.
Xdemvy, specifically formulated as an ectoparasiticide (anti-parasitic) for Demodex blepharitis treatment, contains the active ingredient lotilaner, a member of the isoxazoline compound family. In both Saturn-1 and Saturn-2 trials, Xdemvy showcased significant efficacy. How Does Xdemvy Work?
The Phase 1 clinical trial is planned to be conducted in Canada and targeted to recruit up to 48 and 24 healthy volunteers for the single-ascending dose (SAD) and multiple- ascending dose (MAD) cohorts, respectively.
This impacts the skin’s ability to protect against irritants, bacteria, and allergens. When choosing a soap, read the label and avoid any antibacterial or deodorant soaps that contain irritants, such as fragrances, dyes, or other harsh chemicals. Find a Clinical Trial for Atopic Dermatitis. What Causes Atopic Dermatitis?
Investigations show that these counterfeit ivermectin tablets are systematically underdosed or seriously contaminated with bacteria. Although several health authorities warned the public against using this medicine outside clinical trials, the medicine was widely used on a major scale in late 2020 and in 2021.
Genomics also means we will be able to stratify patients, based upon their genomic makeup, to make clinical trials much more efficient and targeted. While the clinical trial was successful in stopping seizures in around 72% of patients, which is an amazing result, nearly one third of patients did not respond.
Phase I safety, tolerability, and pharmacokinetic study in healthy volunteers expected to start in coming weeks following acceptance of a request for a Clinical Trial Authorization (CTA) granted by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
ALLSCHWIL, Switzerland, Dec.
Polyphor is currently conducting the Phase III FORTRESS trial with balixafortide, a potent and selective CXCR4 antagonist, in patients with HER2 negative, locally recurrent or metastatic breast cancer. OMPTA are potentially the first new class of antibiotics in clinical development in the last 50 years against Gram-negative bacteria.
“We are pleased with the DSMB recommendation that the Phase III clinical trial continues without any protocol modification,” said Frank Weber, MD, CMDO of Polyphor. For more information about the POL6326-009 clinical trial of balixafortide, please visit www.clinicaltrials.gov (Identifier: NCT03786094).
Pending Health Canada’s approval, the Phase 1 trial is designed to test the safety, tolerability and pharmacokinetics of ALS-4 in healthy volunteers. The primary objective of the trial is to evaluate the safety and tolerability of SAD and MAD of ALS-4 administered orally to healthy subjects. About Aptorum Group.
Randomized controlled trials assessing the clinical efficacy of VAXNEUVANCE compared to PCV13 have not been conducted. Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus. Pneumococcal disease is an infection caused by bacteria called Streptococcus pneumoniae, or pneumococcus.
Some people in clinical trials of the Oxford-AstraZeneca vaccine were given the two doses several months apart. Adding to the list of sketchy hand sanitizers and mouthwashes, a hand sanitizer has been recalled because it may contain methanol, a toxic chemical known as wood alcohol, CBS News reported Tuesday. Shane Erickson Inc.
According to recent figures, more than one-third of consumers worldwide are trying to reduce their consumption of products containing eggs from industrial farming and 13 percent do not eat them at all. One of the company’s first egg-replacement trials was done with muffins.
Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.? For more information, refer to [link].
Daktarin is a sugar-free, orange flavour oral gel which contains 2% of miconazole , an antifungal drug. The following restrictions exist on the availability and supply of Daktarin Oral Gel: Daktarin Oral Gel is a pharmacy-only medicine.
There are more than 90 different types of pneumococcal bacteria which can affect adults differently than children. The global prevalence of pneumococcal disease, an infection caused by bacteria called Streptococcus pneumoniae , is evolving. Plans for global regulatory licensure applications, beginning with the U.S.
Nasdaq: SYBX ), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced SYNB1891 has advanced into the combination therapy stage of the ongoing Phase 1 trial. SYNB1891 is being evaluated in a Phase 1 clinical trial. CAMBRIDGE, Mass. , 14, 2020 /PRNewswire/ — Synlogic, Inc.
Nasal sprays for the management of blocked nose in babies usually contain the hypertonic saline solution, which has a decongestion effect. A hypertonic solution contains higher concentration (amount) of salt than fluids found in the body. Calpol Saline Nasal Spray contains 0.9% Products discussed below can be used from birth.
Like troops at the forefront of any battle, our immune system continually marches to protect us from foreign elements and invaders, including bacteria, viruses, and others. It contains fibrinogen is comparatively a cheaper alternative; however, requires the administration of large quantities of fluid to achieve a reasonable fibrinogen dose.
A gentle cleanser can help remove dirt, bacteria, and excess oils without stripping the skin of its natural protective barrier. Moisturize with a lotion or cream containing ceramides, hyaluronic acid, or glycerin. You can contribute to this essential work by participating in our clinical trials.
The vaccine also contains capsular polysaccharide conjugates for seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) that cause invasive pneumococcal disease (IPD), 8,9,10,11,12 and have been associated with high case-fatality rates, 13,14,15,16 antibiotic resistance, 4,17,18 and/or meningitis. IMPORTANT SAFETY INFORMATION.
Fosmanogepix is currently in Phase 2 clinical trials evaluating the safety and efficacy of both intravenous (IV) and oral formulations for the treatment of patients with life-threatening invasive fungal infections caused by molds, yeasts and rare molds (e.g., The information contained in this release is as of April 28, 2021.
Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. This press release contains forward-looking statements. Safe Harbor Statement.
coli bacteria, as well as lambda bacteriophage, can adapt to the alterations in the composition of their nutrient medium. Further, the transcription factors contain two molecular domains, the DNA binding domain and the activation domain.
It contains the antiviral medications nirmatrelvir and ritonavir. This is largely due to failed trials as a prophylaxis resulting in the European Committee for Medical Products (CHMP) recommending against the approval of Lagevrio. Pfizer’s total global revenue from Paxlovid was $18.93 billion in 2022. billion in 2022. and $16,382.51
The air of a hospital is not so clean and containsbacteria.”. Dr. Durand explains that the bacteria-laden air can cause bacteria to be deposited in the lungs, leading to pneumonia and then sepsis. The device has biosensors that contain nanochannels with nano-scale dimensions.
By exploring key metrics from sales figures and pricing structures to clinical trial outcomes and regulatory milestones this analysis provides a snapshot of how these drugs are meeting both patient needs and business objectives. A Phase III clinical trial program assessed Shingrix’s efficacy in over 38,000 participants.
It includes a range of viruses, bacteria and other infectious agents considered to pose the greatest threat to public health in the event of an outbreak. Due to growing concerns over resistance to existing antibiotics, it also includes bacteria such as those causing gonorrhoea. The agency said there is no ranking within the list.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content